Men exposed to intermediate compared with low diagnostic activity, corresponding to diagnostic activity after the introduction of PSA testing in Sweden, had a 4% excess lifetime risk of a prostate cancer diagnosis. The gene discussed is KLK3; the disease is Familial prostate cancer.